ZHEJIANG JIANFENG GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.73 CNY | +0.23% |
|
+0.69% | -21.00% |
| Sales 2021 | 3.81B 525M | Sales 2022 | 3.56B 491M | Capitalization | 4.38B 605M |
|---|---|---|---|---|---|
| Net income 2021 | 924M 128M | Net income 2022 | 288M 39.75M | EV / Sales 2021 | 1.6 x |
| Net cash position 2021 | 183M 25.3M | Net Debt 2022 | 109M 15.06M | EV / Sales 2022 | 1.26 x |
| P/E ratio 2021 |
6.81
x | P/E ratio 2022 |
15.2
x | Employees | 2,104 |
| Yield 2021 |
2.74% | Yield 2022 |
1.18% | Free-Float | 76.01% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.23% | ||
| 1 week | +0.69% | ||
| Current month | -4.28% | ||
| 1 month | -4.28% | ||
| 3 months | -17.72% | ||
| 6 months | -21.77% | ||
| Current year | -21.00% |
1 week
8.56
8.77
1 month
8.389.36
Current year
7.9411.24
1 year
7.9412.54
3 years
7.9425.65
5 years
7.9425.65
10 years
7.9425.65
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Hong Yu
CEO | Chief Executive Officer | 58 | 08-09-04 |
Xiao Long Lan
DFI | Director of Finance/CFO | 51 | 14-11-11 |
Jin Long Huang
BRD | Director/Board Member | 59 | 08-09-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Meng Jiang
CHM | Chairman | 60 | 07-08-16 |
Jian Hong Yu
CEO | Chief Executive Officer | 58 | 08-09-04 |
Xu Ping Qin
BRD | Director/Board Member | 61 | 11-11-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 8.73 | +0.23% | 2,520,181 |
| 24-04-25 | 8.71 | +1.04% | 2,117,498 |
| 24-04-24 | 8.62 | -0.12% | 1,762,405 |
| 24-04-23 | 8.63 | -0.12% | 1,851,652 |
| 24-04-22 | 8.64 | -0.35% | 1,752,617 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
ZHE JIANG JIAN FENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture and distribution of cement and pharmaceuticals. The Company mainly conducts its cement business in Hubei Province, Yunnan Province, Zhejiang Province and Guangxi Province. The Company provides pharmaceuticals, including anti-infective drugs, antipyretic and analgesic drugs, drugs for cardiovascular system diseases, drugs for diabetes mellitus, bulk drugs, intermediates and over the counter (OTC) products. The Company is also engaged in the provision of health products, and the manufacture and distribution of cables. The Company conducts its business in domestic markets.
Sector
Construction Materials
Calendar
2024-04-29
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -21.00% | 414M | |
| +19.81% | 47.84B | |
| -2.89% | 15.44B | |
| -1.00% | 15.27B | |
| -15.75% | 10.38B | |
| +26.55% | 8.75B | |
| +105.28% | 8.61B | |
| -0.30% | 7.84B | |
| -8.75% | 7.39B | |
| +23.60% | 6.64B |
- Stock Market
- Equities
- 600668 Stock
